Q2 2024 Earnings Call August 8, 2024 Welcome and Introduction JOHN SCARLETT, M.D. Chairman and Chief Executive Officer ANDREW J. GRETHLEIN, PH.D. EVP, Chief Operating Officer; Interim Commercial Lead FAYE FELLER, M.D. EVP, Chief Medical Officer MICHELLE ROBERTSON EVP, Chief Financial Officer 2 Forward-Looking Statements During the course of this presentation and question-and-answer session, there will be forward-looking statements regarding future events, performance, plans, expectations and other projectio ...